Kurtuluş Aksu

1.4k total citations
50 papers, 296 citations indexed

About

Kurtuluş Aksu is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Kurtuluş Aksu has authored 50 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 9 papers in Infectious Diseases. Recurrent topics in Kurtuluş Aksu's work include Asthma and respiratory diseases (20 papers), Respiratory and Cough-Related Research (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Kurtuluş Aksu is often cited by papers focused on Asthma and respiratory diseases (20 papers), Respiratory and Cough-Related Research (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Kurtuluş Aksu collaborates with scholars based in Türkiye, Kuwait and Cambodia. Kurtuluş Aksu's co-authors include Emel Kurt, Özkan Alataş, Hale Ateş, Selma Fırat, Bünyamin Yavuz, Nermin Çapan, Zafer Gülbaş, Kadir Okhan Akın, Tuğrul Şipit and Pınar Özkan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical & Experimental Immunology and Cytokine.

In The Last Decade

Kurtuluş Aksu

35 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurtuluş Aksu Türkiye 11 144 109 41 38 36 50 296
Emin Özkaya Türkiye 13 150 1.0× 92 0.8× 47 1.1× 91 2.4× 35 1.0× 33 344
Hans‐Werner Duchna Germany 10 132 0.9× 131 1.2× 6 0.1× 10 0.3× 10 0.3× 24 295
Ming Chih Chou Taiwan 11 67 0.5× 85 0.8× 7 0.2× 58 1.5× 9 0.3× 15 367
Jessica Brussee Netherlands 8 254 1.8× 161 1.5× 14 0.3× 99 2.6× 7 0.2× 8 390
Vivian H. Shih United States 8 268 1.9× 164 1.5× 33 0.8× 166 4.4× 33 0.9× 23 477
Deepak P. Chandrasekharan United Kingdom 8 126 0.9× 82 0.8× 4 0.1× 23 0.6× 23 0.6× 13 306
R. Jankowski France 8 165 1.1× 70 0.6× 18 0.4× 182 4.8× 5 0.1× 18 327
Anna von Bülow Denmark 14 460 3.2× 309 2.8× 15 0.4× 99 2.6× 78 2.2× 36 551
Pınar Yıldız Gülhan Türkiye 10 46 0.3× 68 0.6× 4 0.1× 14 0.4× 11 0.3× 46 216
Aysel Vehapoğlu Türkiye 11 59 0.4× 18 0.2× 15 0.4× 4 0.1× 9 0.3× 28 315

Countries citing papers authored by Kurtuluş Aksu

Since Specialization
Citations

This map shows the geographic impact of Kurtuluş Aksu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurtuluş Aksu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurtuluş Aksu more than expected).

Fields of papers citing papers by Kurtuluş Aksu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurtuluş Aksu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurtuluş Aksu. The network helps show where Kurtuluş Aksu may publish in the future.

Co-authorship network of co-authors of Kurtuluş Aksu

This figure shows the co-authorship network connecting the top 25 collaborators of Kurtuluş Aksu. A scholar is included among the top collaborators of Kurtuluş Aksu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurtuluş Aksu. Kurtuluş Aksu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aksu, Kurtuluş. (2025). Mepolizumab and pregnancy: A case of severe eosinophilic asthma in a patient who conceived during mepolizumab treatment. Eurasian Journal of Pulmonology. 62–64. 1 indexed citations
2.
3.
Aksu, Kurtuluş, et al.. (2025). Successful desensitization with FVIII/Von Willebrand Factor concentrate in Type III Von Willebrand Disease. Allergologia et Immunopathologia. 53(6). 141–145.
4.
5.
6.
Aksu, Kurtuluş, et al.. (2024). The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience. Allergy and Asthma Proceedings. 45(4). e46–e53. 2 indexed citations
7.
Erkekol, Ferda Öner, et al.. (2024). Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations. World Allergy Organization Journal. 17(1). 100862–100862. 2 indexed citations
8.
Özdedeoğlu, Özlem, et al.. (2024). What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?. Journal of Asthma and Allergy. Volume 17. 113–122.
9.
Aksu, Kurtuluş, et al.. (2023). A descriptive study evaluating quality of life and factors affecting it in adult asthmatics. Revue française d'allergologie. 63(7). 103705–103705. 1 indexed citations
10.
11.
Ateş, Hale, et al.. (2023). Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions. Allergologia et Immunopathologia. 51(2). 130–136. 1 indexed citations
12.
Aksu, Kurtuluş, et al.. (2023). Variables predicting clinical remission among adults with severe asthma treated with biologic agents. European Annals of Allergy and Clinical Immunology. 56(5). 219–219. 8 indexed citations
13.
14.
Riachy, Moussa, et al.. (2022). Challenges and recommendations for the management of asthma in the Middle East and Africa. Annals of Thoracic Medicine. 17(2). 71–80. 17 indexed citations
15.
Aksu, Kurtuluş, et al.. (2021). Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19. Revista da Associação Médica Brasileira. 67(suppl 1). 97–101. 3 indexed citations
16.
Aksu, Kurtuluş, et al.. (2021). COVID-19 in patients with severe asthma using biological agents. Tuberkuloz ve Toraks. 69(3). 433–436. 10 indexed citations
17.
Ateş, Hale, et al.. (2021). Identification of Risk Factors and Cross-Reactivity of Local Anesthetics Hypersensitivity: Analysis of 14-Years’ Experience. Journal of Asthma and Allergy. Volume 14. 47–58. 16 indexed citations
18.
Ateş, Hale, et al.. (2021). Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic. World Allergy Organization Journal. 14(7). 100558–100558. 7 indexed citations
19.
Aksu, Kurtuluş, et al.. (2020). Does spirometric tests meet the acceptability criteria? Data from a tertiary chest hospital in Turkey. Tuberkuloz ve Toraks. 68(2). 112–117. 3 indexed citations
20.
Aksu, Kurtuluş, et al.. (2012). Eczematous Skin Lesions: Delayed-Type Hypersensitivity Reaction to Subcutaneous Enoxaparin: Case Report. 24(3). 318–321.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emin Özkaya Breakdown of academic impact, for papers by Hans‐Werner Duchna Breakdown of academic impact, for papers by Ming Chih Chou Breakdown of academic impact, for papers by Jessica Brussee Breakdown of academic impact, for papers by Vivian H. Shih Breakdown of academic impact, for papers by Deepak P. Chandrasekharan Breakdown of academic impact, for papers by R. Jankowski Breakdown of academic impact, for papers by Anna von Bülow Breakdown of academic impact, for papers by Pınar Yıldız Gülhan Breakdown of academic impact, for papers by Aysel Vehapoğlu
Rankless by CCL
2026